Safety and Immunogenicity of a Group B Streptococcus Vaccine in Healthy Women

Group B Streptococcus Clinical Trial

Official title:
A Phase Ib Randomized, Observer-Blind, Controlled, Single Center, Dose-Ranging Study of a Group B Streptococcus Vaccine in Healthy Women 18-40 Years of Age

Status Completed

Clinical Trial Summary

This study will evaluate the safety and immunogenicity of a Group B Streptococcus vaccine.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Group B Streptococcus

Clinical Trial Details

NCT number	NCT01150123
Study type	Interventional
Source	Novartis
Contact
Status	Completed
Phase	Phase 1
Start date	May 2010
Completion date	October 2012

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04059510` - Developing a Controlled Human Infection Model for Group B Streptococcus (CHIM_GBS)
Completed	`NCT02511444` - Intrapartum Rapid GBS Testing in Patients Presenting With Threatened Preterm Labor	N/A
Completed	`NCT00716781` - Management of Infants Born to Group B Streptococcus Positive Mothers.	N/A
Completed	`NCT01982084` - Group B Streptococcus: Attitudes to Immunisation in Pregnancy
Active, not recruiting	`NCT00972894` - Group B Streptococcus (GBS) Polymerase Chain Reaction (PCR) Concordance Study	N/A
Terminated	`NCT00823433` - Oral Penicillin and Penicillin Levels in Venous Umbilical Cord Blood	Phase 0
Completed	`NCT01251289` - The Prevalence of Group B Streptococcus Positive Pregnant Patients in an Inner City Tertiary Care Center
Completed	`NCT01180023` - Membrane Sweeping in Group B Streptococcus (GBS) Positive Patients	N/A
Completed	`NCT00008853` - Evaluation of Two Type III GBS Polysaccharide-Tetanus Toxoid Conjugate Vaccines	Phase 1